BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11908871)

  • 1. Localization of gelatinase activities in glioma tissues by film in situ zymography.
    Takano S; Tsuboi K; Matsumura A; Sato H; Nose T
    Brain Tumor Pathol; 2001; 18(2):145-50. PubMed ID: 11908871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased in situ gelatinolytic activity in renal cell tumor tissues correlates with tumor size, grade and vessel invasion.
    Kamiya N; Kishimoto T; Suzuki H; Sekita N; Nagai Y; Oosumi N; Kito H; Tochigi N; Shinbo M; Nemori R; Ichikawa T; Igarashi T; Ito H; Ishikura H
    Int J Cancer; 2003 Sep; 106(4):480-485. PubMed ID: 12845641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
    Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
    Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR
    Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ gelatinolytic activity correlates with tumor progression and prognosis in patients with bladder cancer.
    Kawamura K; Kamiya N; Suyama T; Shimbo M; Oosumi N; Suzuki H; Ueda T; Tobe T; Igarashi T; Ito H; Ishikura H
    J Urol; 2004 Oct; 172(4 Pt 1):1480-4. PubMed ID: 15371875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
    Zhao JX; Yang LP; Wang YF; Qin LP; Liu DQ; Bai CX; Nan X; Shi SS; Pei XJ
    Eur J Neurol; 2007 May; 14(5):510-6. PubMed ID: 17437609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medulloblastoma displays distinct regional matrix metalloprotease expression.
    Vince GH; Herbold C; Klein R; Kühl J; Pietsch T; Franz S; Roosen K; Tonn JC
    J Neurooncol; 2001 Jun; 53(2):99-106. PubMed ID: 11716074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
    Rao JS; Yamamoto M; Mohaman S; Gokaslan ZL; Fuller GN; Stetler-Stevenson WG; Rao VH; Liotta LA; Nicolson GL; Sawaya RE
    Clin Exp Metastasis; 1996 Jan; 14(1):12-8. PubMed ID: 8521611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo.
    Sawaya RE; Yamamoto M; Gokaslan ZL; Wang SW; Mohanam S; Fuller GN; McCutcheon IE; Stetler-Stevenson WG; Nicolson GL; Rao JS
    Clin Exp Metastasis; 1996 Jan; 14(1):35-42. PubMed ID: 8521615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
    Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
    J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography.
    Ikeda M; Maekawa R; Tanaka H; Matsumoto M; Takeda Y; Tamura Y; Nemori R; Yoshioka T
    Clin Cancer Res; 2000 Aug; 6(8):3290-6. PubMed ID: 10955815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
    Kachra Z; Beaulieu E; Delbecchi L; Mousseau N; Berthelet F; Moumdjian R; Del Maestro R; Béliveau R
    Clin Exp Metastasis; 1999; 17(7):555-66. PubMed ID: 10845554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
    Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
    Hur JH; Park MJ; Park IC; Yi DH; Rhee CH; Hong SI; Lee SH
    J Korean Med Sci; 2000 Jun; 15(3):309-14. PubMed ID: 10895974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.
    Kubiatowski T; Jang T; Lachyankar MB; Salmonsen R; Nabi RR; Quesenberry PJ; Litofsky NS; Ross AH; Recht LD
    J Neurosurg; 2001 Sep; 95(3):480-8. PubMed ID: 11565871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
    Lampert K; Machein U; Machein MR; Conca W; Peter HH; Volk B
    Am J Pathol; 1998 Aug; 153(2):429-37. PubMed ID: 9708803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detections of matrix metalloproteinases activities and localization by film in situ zymography (FIZ)].
    Muramatsu M; Takai S; Miyazaki M
    Nihon Yakurigaku Zasshi; 2003 Feb; 121(2):113-8. PubMed ID: 12616856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.